DK2895856T3 - Diagnose og behandling af mobilitetsforstyrrelser i tarm og blære, og af fibromyalgi - Google Patents

Diagnose og behandling af mobilitetsforstyrrelser i tarm og blære, og af fibromyalgi

Info

Publication number
DK2895856T3
DK2895856T3 DK13837424.4T DK13837424T DK2895856T3 DK 2895856 T3 DK2895856 T3 DK 2895856T3 DK 13837424 T DK13837424 T DK 13837424T DK 2895856 T3 DK2895856 T3 DK 2895856T3
Authority
DK
Denmark
Prior art keywords
fibromyalgy
diagnosis
blade
treatment
gas
Prior art date
Application number
DK13837424.4T
Other languages
English (en)
Inventor
Mark Pimentel
Christopher Chang
Original Assignee
Cedars Sinai Medical Center
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cedars Sinai Medical Center filed Critical Cedars Sinai Medical Center
Application granted granted Critical
Publication of DK2895856T3 publication Critical patent/DK2895856T3/da

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6887—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids from muscle, cartilage or connective tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/4703—Regulators; Modulating activity
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/06—Gastro-intestinal diseases
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/06—Gastro-intestinal diseases
    • G01N2800/065—Bowel diseases, e.g. Crohn, ulcerative colitis, IBS
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/2842—Pain, e.g. neuropathic pain, psychogenic pain

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Epidemiology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Rehabilitation Therapy (AREA)
  • Rheumatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
DK13837424.4T 2012-09-17 2013-08-19 Diagnose og behandling af mobilitetsforstyrrelser i tarm og blære, og af fibromyalgi DK2895856T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261701923P 2012-09-17 2012-09-17
US201361762632P 2013-02-08 2013-02-08
PCT/US2013/055626 WO2014042828A2 (en) 2012-09-17 2013-08-19 Diagnosis and treatment of motility disorders of the gut and bladder, and of fibromyalgia

Publications (1)

Publication Number Publication Date
DK2895856T3 true DK2895856T3 (da) 2017-11-20

Family

ID=50278832

Family Applications (1)

Application Number Title Priority Date Filing Date
DK13837424.4T DK2895856T3 (da) 2012-09-17 2013-08-19 Diagnose og behandling af mobilitetsforstyrrelser i tarm og blære, og af fibromyalgi

Country Status (10)

Country Link
US (4) US9702884B2 (da)
EP (1) EP2895856B1 (da)
KR (1) KR102203568B1 (da)
AU (1) AU2013315981B2 (da)
CA (1) CA2884413C (da)
DK (1) DK2895856T3 (da)
ES (1) ES2646598T3 (da)
HK (1) HK1207420A1 (da)
MX (2) MX2015003326A (da)
WO (1) WO2014042828A2 (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11693009B2 (en) 2009-02-11 2023-07-04 Cedars-Sinai Medical Center Methods for detecting post-infectious irritable bowel syndrome
US10132814B2 (en) * 2014-10-09 2018-11-20 Cedars-Sinai Medical Center Methods for distinguishing irritable bowel syndrome from inflammatory bowel disease and celiac disease
ES2646598T3 (es) 2012-09-17 2017-12-14 Cedars-Sinai Medical Center Diagnóstico y tratamiento de los trastornos de la motilidad del intestino y la vejiga, y de la fibromialgia
IL244971B2 (en) * 2013-10-09 2023-12-01 Cedars Sinai Medical Center Diagnostic methods and systems for irritable bowel syndrome and inflammatory bowel disease
EP3356384B1 (en) * 2015-09-29 2023-11-29 Paris Sciences et Lettres Polypeptides comprising vinculin binding sites for the treatment of proliferation and/or adhesion related diseases
WO2018140869A1 (en) * 2017-01-30 2018-08-02 Cedars-Sinai Medical Center Diagnosis of scleroderma
CN113447649B (zh) * 2021-07-01 2022-04-19 浙江大学 一种检测抗粘着斑蛋白-IgG抗体的试剂盒

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3425441B2 (ja) 1990-10-22 2003-07-14 ガストロ サービシイズ ピーティーワイ リミテッド 非炎症性及び非感染性腸障害の処置
US5691151A (en) 1994-10-07 1997-11-25 Regents Of University Of California Methods of screening for ulcerative colitis and crohn's disease by detecting VH3-15 autoantibody and panca
US7048906B2 (en) 1995-05-17 2006-05-23 Cedars-Sinai Medical Center Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions
US6861053B1 (en) 1999-08-11 2005-03-01 Cedars-Sinai Medical Center Methods of diagnosing or treating irritable bowel syndrome and other disorders caused by small intestinal bacterial overgrowth
US6562629B1 (en) * 1999-08-11 2003-05-13 Cedars-Sinai Medical Center Method of diagnosing irritable bowel syndrome and other disorders caused by small intestinal bacterial overgrowth by detecting the presence of anti-saccharomyces cerivisiae antibodies (asca) in human serum
FR2806805A1 (fr) 2000-03-22 2001-09-28 Centre Nat Rech Scient SEQUENCE PEPTIDIQUES COMPRENANT UN OU PLUSIEURS MOTIFS DE LIAISON AUX PROTEINES DE LA FAMILLE Ena/VASP, ET LEURS UTILISATIONS
US20030157159A1 (en) 2002-01-15 2003-08-21 Franklin Lanny Udell Prevention and treatment of digestive tract infections
WO2003097854A2 (en) 2002-05-17 2003-11-27 Sugen, Inc. Novel biomarkers of tyrosine kinase inhibitor exposure and activity in mammals
DE60330161D1 (de) 2002-08-29 2009-12-31 Activbiotics Pharma Llc Rifalazil zur behandlung von infektionen mit clostridium difficile
EP2444409A2 (en) 2002-09-16 2012-04-25 Genentech, Inc. Compositions and methods for the treatment of immune related diseases
US7595386B2 (en) 2003-01-24 2009-09-29 William Beaumont Hospital Methods and compositions for heat activated gene therapy using cytolethal distending toxin
EP2280285A1 (en) 2003-09-15 2011-02-02 Oklahoma Medical Research Foundation Method of using cytokine assays to diagnose, treat, and evaluate inflammatory and autoimmune diseases
CN103397041B (zh) 2003-12-05 2015-03-11 扶桑药品工业株式会社 细胞致死肿胀毒素及以其为目标的弯曲杆菌属细菌的检测
US20090233888A1 (en) 2005-03-23 2009-09-17 Usc Stevens, University Of Southern California Treatment of disease conditions through modulation of hydrogen sulfide produced by small intestinal bacterial overgrowth
CA2659874C (en) 2006-08-02 2016-10-11 Salix Pharmaceuticals, Inc. Methods for the treatment of radiation proctosigmoiditis
EP2102367A2 (en) 2006-11-09 2009-09-23 XDX, Inc. Methods for diagnosing and monitoring the status of systemic lupus erythematosus
AU2008273699A1 (en) 2007-07-06 2009-01-15 Lupin Limited Pharmaceutical compositions of rifaximin
DK2223121T3 (da) * 2007-12-20 2012-10-22 Index Diagnostics Ab Publ Fremgangsmåde og kit til anvendelse ved differentiering mellem ibd og ibs og yderligere skelnen mellem ibd-sygdomstyper
PL2252148T3 (pl) 2008-02-26 2019-09-30 Salix Pharmaceuticals, Ltd. Sposoby leczenia zespołu jelita drażliwego
GB2460717A (en) * 2008-06-11 2009-12-16 Sense Proteomic Ltd Autoantibodies for the detection of a predisposition to Lupus
ES2529060T3 (es) 2008-11-24 2015-02-16 Cedars-Sinai Medical Center Derivados antioxidantes de la camptotecina y nanoesferas antineoplásicas antioxidantes de los mismos
US10132814B2 (en) 2014-10-09 2018-11-20 Cedars-Sinai Medical Center Methods for distinguishing irritable bowel syndrome from inflammatory bowel disease and celiac disease
US20110294726A1 (en) 2009-02-11 2011-12-01 Cedars-Sinai Medical Center Antibiotic therapy to reduce the likelihood of developing post-infectious irritable bowel syndrome
US9110081B2 (en) 2009-02-11 2015-08-18 Cedars-Sinai Medical Center Antibody to cytolethal distending toxin of Campylobacter jejuni
FR2942541A1 (fr) * 2009-02-25 2010-08-27 Assist Publ Hopitaux De Paris Procede de diagnostic d'une vascularite
RU2397178C1 (ru) 2009-02-27 2010-08-20 Федеральное государственное учреждение науки "Центральный научно-исследовательский институт эпидемиологии" Федеральной службы по надзору в сфере защиты прав потребителей и благополучия человека Диагностическая тест-система в формате иммуночипа и способ серологической дифференциальной диагностики сифилиса
IT1400989B1 (it) * 2010-07-13 2013-07-05 Segix Italia S R L Ora Istituto Biochimico Naz Savio S R L Forme di somministrazione orale a rilascio controllato di rifampicina per il trattamento di infezioni batteriche dell' apparato intestinale.
GB201017520D0 (en) 2010-10-15 2010-12-01 Sense Proteomic Ltd Biomarkers
ES2646598T3 (es) 2012-09-17 2017-12-14 Cedars-Sinai Medical Center Diagnóstico y tratamiento de los trastornos de la motilidad del intestino y la vejiga, y de la fibromialgia
IL244971B2 (en) 2013-10-09 2023-12-01 Cedars Sinai Medical Center Diagnostic methods and systems for irritable bowel syndrome and inflammatory bowel disease
WO2018140869A1 (en) 2017-01-30 2018-08-02 Cedars-Sinai Medical Center Diagnosis of scleroderma

Also Published As

Publication number Publication date
US20180364255A1 (en) 2018-12-20
AU2013315981B2 (en) 2019-04-18
US9952223B2 (en) 2018-04-24
US10466254B2 (en) 2019-11-05
EP2895856A4 (en) 2016-06-08
EP2895856A2 (en) 2015-07-22
ES2646598T3 (es) 2017-12-14
MX2015003326A (es) 2015-08-12
KR102203568B1 (ko) 2021-01-15
EP2895856B1 (en) 2017-10-04
WO2014042828A3 (en) 2014-10-16
KR20150058404A (ko) 2015-05-28
US20150233944A1 (en) 2015-08-20
US9702884B2 (en) 2017-07-11
WO2014042828A2 (en) 2014-03-20
US20180088130A1 (en) 2018-03-29
CA2884413C (en) 2022-11-01
US20200271665A1 (en) 2020-08-27
AU2013315981A1 (en) 2015-03-26
HK1207420A1 (en) 2016-01-29
MX2021003764A (es) 2021-05-27
CA2884413A1 (en) 2014-03-20

Similar Documents

Publication Publication Date Title
LTC3057969I2 (lt) Kompozicijos, naudojamos gydyti sutrikimams, susijusiems su kit
DK2685887T3 (da) Personlig eeg-overvågningsindretning med elektrodevalidering
DK2895856T3 (da) Diagnose og behandling af mobilitetsforstyrrelser i tarm og blære, og af fibromyalgi
BR112015003320A2 (pt) aparelhos e métodos eletrocirúrgicos.
DK3421486T3 (da) Nye Vista-IG-konstruktioner og anvendelse af Vista-IG til behandling af autoimmune, allergiske og inflammatoriske lidelser
DK2935303T3 (da) 4`-fluornukleosider, 4`-fluornukleotider og analoger dertil til behandling af HCV
BR112014010175A2 (pt) unidades de filtro, componentes e recursos destas e métodos de uso e construção
DK2815769T3 (da) Fam19a5 til anvendelse i diagnosticering og behandling af skader på centralnervesystemet
DK2753632T3 (da) Neuroaktive steroider, sammensætninger og anvendelse heraf
ZA201402948B (en) Mobile treatment, diagnostic and minor surgery facility
DK2927311T3 (da) Celleovervågningsindretning, celleovervågningsfremgangsmåde og program dertil
BR112013009708A2 (pt) aparelhos, métodos e composições para tratamento endodôntico
BR112013013584A2 (pt) endoscópio, e, método
ITMI20120590A1 (it) Girante e turbomacchinario includente la girante.
DK3027208T3 (da) Cancerdiagnose og -terapi, der involverer cancerstamceller
BR112012031232A2 (pt) método, dispositivo e uso
BR112014033075A2 (pt) dispositivo de gaxeta, e, turbomáquina.
DK3388687T3 (da) Spændingsapplikationsindretning, rotationsapparat og spændingsapplikationsfremgangsmåde
DK2900279T3 (da) Grpr-antagonister til detektering, diagnose og behandling af grpr-positiv cancer
DK2827813T3 (da) Kuldebehandlingsindretning
BR112014010288A2 (pt) métodos, composição e aparelho refrigerador
DK2877736T3 (da) Skrue, skruedel og fremgangsmåde dertil
BR112014007442A2 (pt) instrumento oftalmológico, e, método
DK2688588T3 (da) Hurtig- og langtidsvirkende immunologisk terapeutisk middel
DK2816947T3 (da) Endoskopisk anordning, særlig til medicinsk brug